296 related articles for article (PubMed ID: 27543314)
1. DNA repair mechanisms and their clinical impact in glioblastoma.
Erasimus H; Gobin M; Niclou S; Van Dyck E
Mutat Res Rev Mutat Res; 2016; 769():19-35. PubMed ID: 27543314
[TBL] [Abstract][Full Text] [Related]
2. DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets.
Lozinski M; Bowden NA; Graves MC; Fay M; Tooney PA
Cell Oncol (Dordr); 2021 Oct; 44(5):961-981. PubMed ID: 34057732
[TBL] [Abstract][Full Text] [Related]
3. Treatment considerations for MGMT-unmethylated glioblastoma.
Taylor JW; Schiff D
Curr Neurol Neurosci Rep; 2015 Jan; 15(1):507. PubMed ID: 25394859
[TBL] [Abstract][Full Text] [Related]
4. The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment.
Annovazzi L; Caldera V; Mellai M; Riganti C; Battaglia L; Chirio D; Melcarne A; Schiffer D
Int J Oncol; 2015; 46(6):2299-308. PubMed ID: 25892134
[TBL] [Abstract][Full Text] [Related]
5. Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide.
Messaoudi K; Clavreul A; Lagarce F
Drug Discov Today; 2015 Jul; 20(7):899-905. PubMed ID: 25744176
[TBL] [Abstract][Full Text] [Related]
6. Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma.
Ferri A; Stagni V; BarilĂ D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664581
[TBL] [Abstract][Full Text] [Related]
7. Updated Insights on EGFR Signaling Pathways in Glioma.
Oprita A; Baloi SC; Staicu GA; Alexandru O; Tache DE; Danoiu S; Micu ES; Sevastre AS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435537
[TBL] [Abstract][Full Text] [Related]
8. Molecular targets in glioblastoma.
Zorzan M; Giordan E; Redaelli M; Caretta A; Mucignat-Caretta C
Future Oncol; 2015; 11(9):1407-20. PubMed ID: 25952786
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways.
Chaudhry MA; Sachdeva H; Omaruddin RA
DNA Cell Biol; 2010 Sep; 29(9):553-61. PubMed ID: 20380575
[TBL] [Abstract][Full Text] [Related]
10. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
11. Broken beyond repair. Damaging DNA in glioblastoma cells with radiation and camptothecin.
Darzynkiewicz Z
Cancer Biol Ther; 2008 Mar; 7(3):374-5. PubMed ID: 18614857
[No Abstract] [Full Text] [Related]
12. The DNA methylome of glioblastoma multiforme.
Martinez R; Esteller M
Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma multiforme: Pathogenesis and treatment.
Alifieris C; Trafalis DT
Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
[TBL] [Abstract][Full Text] [Related]
14. Key concepts in glioblastoma therapy.
Bartek J; Ng K; Bartek J; Fischer W; Carter B; Chen CC
J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):753-60. PubMed ID: 22396442
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.
Parker NR; Hudson AL; Khong P; Parkinson JF; Dwight T; Ikin RJ; Zhu Y; Cheng ZJ; Vafaee F; Chen J; Wheeler HR; Howell VM
Sci Rep; 2016 Mar; 6():22477. PubMed ID: 26940435
[TBL] [Abstract][Full Text] [Related]
16. Association between response to primary treatments and MGMT status in glioblastoma.
Franceschi E; Tosoni A; Pozzati E; Brandes AA
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1781-6. PubMed ID: 18983238
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.
Johannessen TC; Bjerkvig R
Expert Rev Anticancer Ther; 2012 May; 12(5):635-42. PubMed ID: 22594898
[TBL] [Abstract][Full Text] [Related]
18. GBM radiosensitizers: dead in the water…or just the beginning?
Bindra RS; Chalmers AJ; Evans S; Dewhirst M
J Neurooncol; 2017 Sep; 134(3):513-521. PubMed ID: 28762004
[TBL] [Abstract][Full Text] [Related]
19. Advances in epigenetic glioblastoma therapy.
Lee DH; Ryu HW; Won HR; Kwon SH
Oncotarget; 2017 Mar; 8(11):18577-18589. PubMed ID: 28099914
[TBL] [Abstract][Full Text] [Related]
20. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]